Verastem (VSTM)

[realfast95]

Details of the agreement with Secura Bio on August 10th
Perhaps this is why the the stock didn't move. The deal is spread out. They are burning 13m/Qtr or 52m/yr

Secura Bio has agreed to pay the Company an up-front payment of $70.0 million in cash payable at the closing of the Transaction

After the Closing regulatory milestone payments of $35.0 million upon receipt of regulatory approval of COPIKTRA in the United States for the treatment of peripheral T-cell lymphoma

Payent of $10.0 million upon receipt of the first regulatory approval for the commercial sale of COPIKTRA in the European Union for the treatment of peripheral T-cell lymphoma.

Sales milestone payments consisting of $10.0 million when total worldwide net sales of COPIKTRA exceed $100.0 million,

$15.0 million when total worldwide net sales of COPIKTRA exceed $200.0 million

$25.0 million when total worldwide net sales of COPIKTRA exceed $300.0 million,

low double-digit royalties on the annual aggregate net sales above $100.0 million in the United States and Europe

50% of all royalty, milestone and sublicense revenue payments payable to Secura Bio under the Company’s existing license agreements with Sanofi, Yakult Honsha Co., Ltd. and CSPC Pharmaceutical Group Limited, each of which will transfer to Secura Bio at the Closing.

50% of all royalty and milestone payments payable to Secura Bio under any license or sublicense agreement entered into by Secura Bio after the Closing in certain jurisdictions.